MicroRNA-630 alleviates inflammatory reactions in rats with diabetic kidney disease by targeting toll-like receptor 4

doi:10.4239/wjd.v15.i3.488

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2166)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-1) series.

Item

Count

PDF

WORD

HTML

1196

Figures (1-5)

164

Tables (1-1)

174

Sum=1627

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

130

Download

315

Sum=445

Mar 15, 2024 (publication date) through Dec 23, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Diabetes. Mar 15, 2024; 15(3): 488-501
Published online Mar 15, 2024. doi: 10.4239/wjd.v15.i3.488

Full Size Figure Download Figure

Figure 5 Effects of overexpression of miR-630 on glomerular morphology in diabetic kidney disease rats. A: Effect of overexpression of miR-630 on glomerular morphology in diabetic kidney disease (DKD) rats (hematoxylin and eosin, × 200); B: Effect of overexpression of miR-630 on glomerular morphology in DKD rats (Masson, × 200). DKD: Diabetic kidney disease; NC agomir: Negative control of lentivirus.

Citation: Wu QS, Zheng DN, Ji C, Qian H, Jin J, He Q. MicroRNA-630 alleviates inflammatory reactions in rats with diabetic kidney disease by targeting toll-like receptor 4. World J Diabetes 2024; 15(3): 488-501
URL: https://www.wjgnet.com/1948-9358/full/v15/i3/488.htm
DOI: https://dx.doi.org/10.4239/wjd.v15.i3.488